ACCRETION PHARMA LIMITED — Quarterly Results & Earnings

₹63.55

-0.08%

Profit Growth YoY93.09%Latest quarter

Sales Growth YoY135.67%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+93.09%

🔥 Exceptional growth

YoY Sales Growth+135.67%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

12.60

ROE

65.35%

ROCE

46.36%

💡

Growth Analysis

ACCRETION PHARMA LIMITED reported YoY profit growth of 93.09% and revenue growth of 135.67% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on ACCRETION PHARMA LIMITED

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.